SCHEMBL17629888

SCHEMBL17629888

Cc1cc(C(=O)O)ccc1-c1ccc(-n2ccnc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADH5 P11766 14/20 1.00
CYP3A4 P08684 1/20 0.56
BAZ2B Q9UIF8 1/20 0.56
HTT P42858 2/20 0.52
CYP4Z1 Q86W10 1/20 0.51
MEN1 O00255 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
KMT2A Q03164 1/20 0.49
CYP2C19 P33261 1/20 0.48
NPC1 O15118 1/20 0.48
ALDH1A1 P00352 1/20 0.48
GAA P10253 1/20 0.48
MAPT P10636 1/20 0.48
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
PDE3B Q13370 1/20 0.48
PDE3A Q14432 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17630071 0.92 ADH5 (1.00) ADH5CYP3A4BAZ2BHTTCYP4Z1
SCHEMBL17629973 0.85 ADH5 (1.00) ADH5CYP3A4BAZ2BHTTCYP4Z1
SCHEMBL17643516 0.85 ADH5 (0.73) ADH5CYP3A4BAZ2BHTTCYP4Z1
SCHEMBL17630095 0.85 ADH5 (1.00) ADH5CYP3A4BAZ2BHTTCYP4Z1
SCHEMBL17629943 0.84 ADH5 (0.72) ADH5CYP3A4BAZ2BHTTCYP4Z1
SCHEMBL17630068 0.82 ADH5 (1.00) ADH5CYP3A4BAZ2BHTTCYP4Z1
SCHEMBL62049 0.80 ADH5 (0.90) ADH5CYP3A4BAZ2BHTTCYP4Z1
SCHEMBL17630105 0.80 ADH5 (1.00) ADH5CYP3A4BAZ2BHTTNPC1
SCHEMBL17679919 0.79 ADH5 (0.65) ADH5CYP3A4BAZ2BHTTCYP4Z1
Hydrochloric Acid SCHEMBL6152702 0.79 ADH5 (0.87) ADH5CYP3A4BAZ2BHTTCYP4Z1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016046782-A1 IMIDAZOLE BIARYL COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2016-03-31 WO disclosed